Related Experiment Video
Updated: Sep 23, 2025
Rapid Depletion of Renal Macrophages using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation
Yao-Zhong Kong1, Qiyan Chen1, Hui-Yao Lan2
1Nephrology Department, The First People's Hospital of Foshan, Foshan 528000, China.
Abstract:
Renal inflammation is an initial pathological process during progressive renal injury regardless of the initial cause. Macrophage migration inhibitory factor (MIF) is a truly proinflammatory stress mediator that is highly expressed in a variety of both inflammatory cells and intrinsic kidney cells. MIF is released from the diseased kidney immediately upon stimulation to trigger renal inflammation by activating macrophages and T cells, and promoting the production of proinflammatory cytokines, chemokines, and stress molecules via signaling pathways involving the CD74/CD44 and chemokine receptors CXCR2, CXCR4, and CXCR7 signaling. In addition, MIF can function as a stress molecule to counter-regulate the immunosuppressive effect of glucocorticoid in renal inflammation. Given the critical position of MIF in the upstream inflammatory cascade, this review focuses on the regulatory role and molecular mechanisms of MIF in kidney diseases. The therapeutic potential of targeting MIF signaling to treat kidney diseases is also discussed.
Insights
Macrophage migration inhibitory factor (MIF) drives kidney inflammation by activating immune cells and promoting inflammatory signals. Targeting MIF offers a potential therapeutic strategy for kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Renal inflammation is a key factor in progressive kidney injury.
- Macrophage migration inhibitory factor (MIF) is a potent pro-inflammatory mediator found in kidney cells.
- MIF plays a critical role in initiating and amplifying renal inflammation.
Purpose of the Study:
- To review the regulatory role and molecular mechanisms of MIF in kidney diseases.
- To discuss the therapeutic potential of targeting MIF signaling pathways for treating kidney diseases.
Main Methods:
- Review of existing literature on MIF's role in renal inflammation.
- Analysis of signaling pathways involving MIF, including CD74/CD44 and chemokine receptors (CXCR2, CXCR4, CXCR7).
- Discussion of MIF's counter-regulatory effects on glucocorticoid immunosuppression.
Main Results:
- MIF triggers renal inflammation by activating macrophages and T cells.
- MIF promotes the production of cytokines, chemokines, and stress molecules.
- MIF acts as a stress molecule that can counteract glucocorticoid effects in renal inflammation.
Conclusions:
- MIF is a central upstream mediator in the inflammatory cascade of kidney diseases.
- Targeting MIF signaling presents a promising therapeutic avenue for various kidney conditions.
